Legal & General Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.17M | Buy |
|
|||||
|
2025
Q2 | $3.46M | Buy |
|
|||||
|
2025
Q1 | $2.93M | Buy |
|
|||||
|
2024
Q4 | $4.7M | Sell |
|
|||||
|
2024
Q3 | $2.69M | Buy |
|
|||||
|
2024
Q2 | $2.74M | Sell |
|
|||||
|
2024
Q1 | $2.64M | Sell |
|
|||||
|
2023
Q4 | $2.87M | Buy |
|
|||||
|
2023
Q3 | $2.89M | Sell |
|
|||||
|
2023
Q2 | $21.2M | Buy |
|
|||||
|
2023
Q1 | $26.6M | Sell |
|
|||||
|
2022
Q4 | $36.8M | Sell |
|
|||||
|
2022
Q3 | $40.8M | Sell |
|
|||||
|
2022
Q2 | $40M | Buy |
|
|||||
|
2022
Q1 | $43.7M | Sell |
|
|||||
|
2021
Q4 | $42.3M | Buy |
|
|||||
|
2021
Q3 | $65.3M | Buy |
|
|||||
|
2021
Q2 | $123M | Buy |
|
|||||
|
2021
Q1 | $68.7M | Buy |
|
|||||
|
2020
Q4 | $51.2M | Buy |
|
|||||
|
2020
Q3 | $10.4M | Buy |
|
|||||
|
2020
Q2 | $5.36M | Buy |
|
|||||
|
2020
Q1 | $4.01M | Buy |
|
|||||
|
2019
Q4 | $4.82M | Buy |
|
|||||
|
2019
Q3 | $3.77M | Buy |
|
|||||
|
2019
Q2 | $2.54M | Buy |
|
|||||
|
2019
Q1 | $1.58M | Buy |
|
|||||
|
2018
Q4 | $1.08M | Buy |
|
|||||
|
2018
Q3 | $1.47M | Buy |
|
|||||
|
2018
Q2 | $868K | Buy |
|
|||||
|
2018
Q1 | $447K | Sell |
|
|||||
|
2017
Q4 | $482K | Sell |
|
|||||
|
2017
Q3 | $502K | Buy |
|
|||||
|
2017
Q2 | $238K | Buy |
|
|||||
|
2017
Q1 | $104K | Sell |
|
|||||
|
2016
Q4 | $100K | Buy |
|